Kidney Cancer Trial, Recruiting NCT03569735 Sponsor: Sun Yat-sen University Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT03569735
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged 65 years or older
  • People who have been living in the Nanshan district of Shenzhen for at least 5 years
  • People who are Chinese

Who may not be able to join:

  • People who have a history of diabetes, heart failure, liver failure, kidney failure, cancer, or cardiovascular disease events that were confirmed by a hospital
  • People who follow a special diet due to a medical condition or for weight control purposes
  • People who have a mental or physical disability
  • People who are likely to move to another city within the next 5 years
  • People who are unwilling to take part in any one part of the surveys or sample collection involved in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yuming Chen, Sun Yat-sen University

Phone: 862087330605

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 May 2018
Est. completion
30 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diabetes mellitus; Cardiovascular diseases (occurrence of cardiovascular diseases); Stroke (occurrence of stroke); Cognitive disorder (occurrence of cognitive disorder)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov